Financials

News Ideas Technicals Forecast

1228 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to CANBRIDGE PHARMACEUTICALS INC operating, investing, and financing activities

1228 free cash flow for H2 23 is -111.35 M HKD. For 2023, 1228 free cash flow was -315.19 M HKD and operating cash flow was -309.09 M HKD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—